GUTS

#4093
Fractyl Health, Inc. Common Stock
0.51 USD
+4.08%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.51
0.51
Range Annuel
0.38
3.03
Changement quotidien
+4.08%
Changement Mensuel
+10.87%
Evolution sur 6 mois
-63.04%
Changement Annuel
-53.64%
Clôture Précédente
0.49
Open
0.51
Bid
Ask
Low
0.51
High
0.51
Volume
13
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 80.91 M
  • Employee 73
  • Founded 2010
  • CEO N/A
  • Website www.fractyl.com
  • Headquarter Delaware, United States
  • FIGI BBG002Y7NH72
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.18
Price to sales ratio
—

Fractyl Health Inc

Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.

Nouvelles